<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Polymorphisms in Turkish population &#187; Ankara</title>
	<atom:link href="http://polymorphisms.info/tag/ankara/feed" rel="self" type="application/rss+xml" />
	<link>http://polymorphisms.info</link>
	<description></description>
	<lastBuildDate>Thu, 19 May 2011 20:57:51 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Association of paraoxonase 55 and 192 gene polymorphisms on serum homocysteine concentrations in preeclampsia.</title>
		<link>http://polymorphisms.info/gene-polymorphisms/paraoxonase-gene-polymorphisms/association-of-paraoxonase-55-and-192-gene-polymorphisms-on-serum-homocysteine-concentrations-in-preeclampsia.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/paraoxonase-gene-polymorphisms/association-of-paraoxonase-55-and-192-gene-polymorphisms-on-serum-homocysteine-concentrations-in-preeclampsia.html#comments</comments>
		<pubDate>Sun, 12 Jul 2009 06:17:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Paraoxonase]]></category>
		<category><![CDATA[Ankara]]></category>
		<category><![CDATA[Arzu]]></category>
		<category><![CDATA[Baskent]]></category>
		<category><![CDATA[Biochemistry]]></category>
		<category><![CDATA[chromatography]]></category>
		<category><![CDATA[Department]]></category>
		<category><![CDATA[Folia]]></category>
		<category><![CDATA[Gurdol]]></category>
		<category><![CDATA[homocysteine]]></category>
		<category><![CDATA[hyperhomocysteinaemia]]></category>
		<category><![CDATA[influence]]></category>
		<category><![CDATA[Isbilen]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[paraoxonase]]></category>
		<category><![CDATA[PCR]]></category>
		<category><![CDATA[plasma]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[Preeclamptic]]></category>
		<category><![CDATA[RFLP]]></category>
		<category><![CDATA[thiolactonase]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[University]]></category>
		<category><![CDATA[Yilmaz]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=240</guid>
		<description><![CDATA[Folia Biol (Praha). 2009;55(2):35-40
Isbilen E, Yilmaz H, Arzu Ergen H, Unlucerci Y, Isbir T, Gurdol F.
Department of Biochemistry, Faculty of Medicine, Baskent University, Ankara, Turkey.
Paraoxonase 1 (PON1) is thought to influence serum homocysteine concentrations, at least in part, due to its homocysteine thiolactonase activity and to play a role in preeclampsia and atherosclerosis. We investigated [...]]]></description>
			<content:encoded><![CDATA[<p><span title="Folia biologica.">Folia Biol (Praha).</span> 2009;55(2):35-40</p>
<p><strong>Isbilen E</strong>, <strong>Yilmaz H</strong>, <strong>Arzu Ergen H</strong>, <strong>Unlucerci Y</strong>, <strong>Isbir T</strong>, <strong>Gurdol F</strong>.</p>
<p>Department of Biochemistry, Faculty of Medicine, Baskent University, Ankara, Turkey.</p>
<p>Paraoxonase 1 (PON1) is thought to influence serum homocysteine concentrations, at least in part, due to its homocysteine thiolactonase activity and to play a role in preeclampsia and atherosclerosis. We investigated the effects of PON 55 and PON 192 polymorphisms on plasma total homocysteine (tHcy) concentrations in preeclamptic and healthy pregnants among Turkish population (N = 106). PON 55 and 192 genotypes were determined by PCR RFLP techniques. Plasma tHcy concentrations were measured by high-performance liquid chromatography. No differences were observed in the distribution of PON 1 55/192 genotypes and allele frequencies between the preeclamptic and healthy pregnants. tHcy level in the plasma of preeclamptic women was found to be increased in comparison with healthy pregnants (P &lt; 0.01). Preeclamptic women bearing the mutated PON 192 RR and wild-type PON1 55 LL genotypes had higher tHcy levels than those of the healthy pregnants with the corresponding genotypes, supporting the possibility that the hyperhomocysteinaemia seen in preeclamptic women is associated with the PON genotypes. However, no influence of the allelic distribution on plasma tHcy concentrations was detected in either group. Our results suggest that PON1 55 and 192 genotypes might have an important role in developing hyperhomocysteinaemia and may also have a role in the pathogenesis of preeclampsia in a Turkish population.</p>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/paraoxonase-gene-polymorphisms/association-of-paraoxonase-55-and-192-gene-polymorphisms-on-serum-homocysteine-concentrations-in-preeclampsia.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome.</title>
		<link>http://polymorphisms.info/capn10/genetic-polymorphisms-of-fshr-cyp17-cyp1a1-capn10-insr-serpine1-genes-in-adolescent-girls-with-polycystic-ovary-syndrome.html</link>
		<comments>http://polymorphisms.info/capn10/genetic-polymorphisms-of-fshr-cyp17-cyp1a1-capn10-insr-serpine1-genes-in-adolescent-girls-with-polycystic-ovary-syndrome.html#comments</comments>
		<pubDate>Wed, 29 Apr 2009 19:39:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[CAPN10]]></category>
		<category><![CDATA[SERPINE1]]></category>
		<category><![CDATA[adolescence]]></category>
		<category><![CDATA[Ankara]]></category>
		<category><![CDATA[Besevler]]></category>
		<category><![CDATA[Bideci]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[CAPN]]></category>
		<category><![CDATA[Cinaz]]></category>
		<category><![CDATA[CYP]]></category>
		<category><![CDATA[Department]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[frequency]]></category>
		<category><![CDATA[Gazi]]></category>
		<category><![CDATA[genet]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[INSR]]></category>
		<category><![CDATA[J Assist]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Menevse]]></category>
		<category><![CDATA[nucleotide]]></category>
		<category><![CDATA[Onen]]></category>
		<category><![CDATA[PCOS]]></category>
		<category><![CDATA[PCR-RFLP]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[SERPINE]]></category>
		<category><![CDATA[SNPs]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[syndrome]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[University]]></category>
		<category><![CDATA[Unsal]]></category>
		<category><![CDATA[Yilmaz]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=230</guid>
		<description><![CDATA[J Assist Reprod Genet. 2009 Apr 22.

Unsal T, Konac E, Yesilkaya E, Yilmaz A, Bideci A, Ilke Onen H, Cinaz P, Menevse A.
Department of Medical Biology and Genetics, Faculty of Medicine, Gazi University, Besevler, 6500, Ankara, Turkey.
BACKGROUND: Polycystic ovary syndrome (PCOS), whose genetic basis is not completely well understood, is the most common endocrine disorder [...]]]></description>
			<content:encoded><![CDATA[<p><span title="Journal of assisted reproduction and genetics."><a href="javascript:AL_get(this, 'jour', 'J Assist Reprod Genet.');">J Assist Reprod Genet.</a></span> 2009 Apr 22.</p>
<dd class="abstract">
<div class="authors"><!--AuthorList--><a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Unsal%20T%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Unsal T</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Konac%20E%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Konac E</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Yesilkaya%20E%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Yesilkaya E</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Yilmaz%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Yilmaz A</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Bideci%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Bideci A</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Ilke%20Onen%20H%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Ilke Onen H</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Cinaz%20P%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Cinaz P</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Menevse%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Menevse A</strong></a>.</div>
<p class="affiliation">Department of Medical Biology and Genetics, Faculty of Medicine, Gazi University, Besevler, 6500, Ankara, Turkey.</p>
<p class="abstract">BACKGROUND: Polycystic ovary syndrome (PCOS), whose genetic basis is not completely well understood, is the most common endocrine disorder in women and it typically develops during adolescence. The aim of this study is to investigate the possible association between single nucleotide polymorphisms (SNPs) of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes and PCOS in adolescent girls. METHODS: DNA samples from forty-four adolescent girls with PCOS and 50 healthy controls were analyzed by PCR-RFLP and direct DNA sequencing to determine the genotypic frequency of 17 different polymorphic loci on the FSHR (A307T, N680S), CYP17 (-34 T/C), CYP1A1 (T6235C), CAPN10 (44, 43, 19, 63), INSR (exon 17 C/T), SERPINE1 (4G/5G) genes. Genotyping of exon 12 (six polymorphisms) and intron 12 (one polymorphism) of INSR gene by direct DNA sequencing was performed for the first time in this study. RESULTS: No significant differences were observed in the genotype and allele distributions of above mentioned polymorphisms between cases and control groups. CONCLUSION: Our data does not support an association between SNPs of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes and susceptibility to PCOS or related traits in Turkish adolescent girls.</p>
</dd>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/capn10/genetic-polymorphisms-of-fshr-cyp17-cyp1a1-capn10-insr-serpine1-genes-in-adolescent-girls-with-polycystic-ovary-syndrome.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Melanocortin-4 receptor gene polymorphisms in obese patients.</title>
		<link>http://polymorphisms.info/gene-polymorphisms/melanocortin-4-receptor/melanocortin-4-receptor-gene-polymorphisms-in-obese-patients-2.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/melanocortin-4-receptor/melanocortin-4-receptor-gene-polymorphisms-in-obese-patients-2.html#comments</comments>
		<pubDate>Wed, 29 Apr 2009 19:35:21 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Melanocortin-4 Receptor]]></category>
		<category><![CDATA[Ankara]]></category>
		<category><![CDATA[Besevler]]></category>
		<category><![CDATA[Biochem]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[cause]]></category>
		<category><![CDATA[com]]></category>
		<category><![CDATA[concordance]]></category>
		<category><![CDATA[correlation]]></category>
		<category><![CDATA[Department]]></category>
		<category><![CDATA[genet]]></category>
		<category><![CDATA[Keles]]></category>
		<category><![CDATA[Kolukisa]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Melanocortin]]></category>
		<category><![CDATA[Menevse]]></category>
		<category><![CDATA[mutation]]></category>
		<category><![CDATA[obese]]></category>
		<category><![CDATA[Ozkurt]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[yahoo]]></category>
		<category><![CDATA[Yetkin]]></category>
		<category><![CDATA[Yilmaz]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=228</guid>
		<description><![CDATA[Biochem Genet. 2009 Apr;47(3-4):295-300.

Yurtcu E, Yilmaz A, Ozkurt Z, Kolukisa E, Yilmaz M, Keles H, Ergun MA, Yetkin I, Menevse A.
Department of Medical Biology and Genetics, Gazi University Faculty of Medicine, Besevler, Ankara, Turkey. erkan_yurtcu@yahoo.com
Obesity is a complex disease caused by both genetics and environmental factors. Melanocortin-4 receptor (MC4R) (MIM 155541) gene polymorphisms were reported [...]]]></description>
			<content:encoded><![CDATA[<p><span title="Biochemical genetics."><a href="javascript:AL_get(this, 'jour', 'Biochem Genet.');">Biochem Genet.</a></span> 2009 Apr;47(3-4):295-300.</p>
<dd class="abstract">
<div class="authors"><!--AuthorList--><a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Yurtcu%20E%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Yurtcu E</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Yilmaz%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Yilmaz A</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Ozkurt%20Z%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Ozkurt Z</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Kolukisa%20E%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Kolukisa E</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Yilmaz%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Yilmaz M</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Keles%20H%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Keles H</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Ergun%20MA%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Ergun MA</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Yetkin%20I%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Yetkin I</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Menevse%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Menevse A</strong></a>.</div>
<p class="affiliation">Department of Medical Biology and Genetics, Gazi University Faculty of Medicine, Besevler, Ankara, Turkey. erkan_yurtcu@yahoo.com</p>
<p class="abstract">Obesity is a complex disease caused by both genetics and environmental factors. Melanocortin-4 receptor (MC4R) (MIM 155541) gene polymorphisms were reported to be the cause of monogenic obesity in humans. We studied three polymorphisms (Val50Met, Val103Ile, and Ser58Cys) and a mutation (Asn274Ser) of the MC4R gene in 203 obese patients and in 110 healthy subjects in the Turkish population. A high incidence of Val103Ile and Val50Met polymorphisms as well as the Asn274Ser mutation was found in the obese patients, whereas no significant correlation was found regarding the Ser58Cys polymorphism. We conclude that there is a concordance between the polymorphisms (Val103Ile, Val50Met, Ser58Cys) that were first studied in the Turkish population with obesity.</p>
</dd>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/melanocortin-4-receptor/melanocortin-4-receptor-gene-polymorphisms-in-obese-patients-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cytotoxic T lymphocyte-associated molecule-4 polymorphism in Turkish patients with Hashimoto thyroiditis.</title>
		<link>http://polymorphisms.info/cancer-kanser/kategorisiz/cytotoxic-t-lymphocyte-associated-molecule-4-polymorphism-in-turkish-patients-with-hashimoto-thyroiditis-2.html</link>
		<comments>http://polymorphisms.info/cancer-kanser/kategorisiz/cytotoxic-t-lymphocyte-associated-molecule-4-polymorphism-in-turkish-patients-with-hashimoto-thyroiditis-2.html#comments</comments>
		<pubDate>Wed, 29 Apr 2009 19:33:28 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Kategorilenmemiş]]></category>
		<category><![CDATA[Ankara]]></category>
		<category><![CDATA[com]]></category>
		<category><![CDATA[Cytotoxic]]></category>
		<category><![CDATA[Diseases]]></category>
		<category><![CDATA[drsahinmustafa]]></category>
		<category><![CDATA[Endocrinology]]></category>
		<category><![CDATA[erdogan]]></category>
		<category><![CDATA[fragment]]></category>
		<category><![CDATA[frequency]]></category>
		<category><![CDATA[goiter]]></category>
		<category><![CDATA[Gursoy]]></category>
		<category><![CDATA[Hashimoto]]></category>
		<category><![CDATA[hormone]]></category>
		<category><![CDATA[hospital]]></category>
		<category><![CDATA[J Immunogenet]]></category>
		<category><![CDATA[Metabolic]]></category>
		<category><![CDATA[method]]></category>
		<category><![CDATA[occurrence]]></category>
		<category><![CDATA[polymerase]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[polymorphisms]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[School]]></category>
		<category><![CDATA[sex]]></category>
		<category><![CDATA[smoking]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[University]]></category>
		<category><![CDATA[yahoo]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=226</guid>
		<description><![CDATA[Int J Immunogenet. 2009 Apr;36(2):103-6.

Sahin M, Gursoy A, Erdogan MF.
Department of Endocrinology and Metabolic Diseases Department, Ankara University School of Medicine, Ibni Sina Hospital, Ankara, Turkey. drsahinmustafa@yahoo.com
We previously shown that in a Turkish population, the A/G polymorphism in exon 1 of the cytotoxic T cell lymphocyte-associated molecule-4 (CTLA-4) gene is associated with Graves&#8217; disease, and [...]]]></description>
			<content:encoded><![CDATA[<p><span title="International journal of immunogenetics."><a href="javascript:AL_get(this, 'jour', 'Int J Immunogenet.');">Int J Immunogenet.</a></span> 2009 Apr;36(2):103-6.<script></script></p>
<dd class="abstract">
<div class="authors"><!--AuthorList--><a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Sahin%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Sahin M</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Gursoy%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Gursoy A</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Erdogan%20MF%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Erdogan MF</strong></a>.</div>
<p class="affiliation">Department of Endocrinology and Metabolic Diseases Department, Ankara University School of Medicine, Ibni Sina Hospital, Ankara, Turkey. drsahinmustafa@yahoo.com</p>
<p class="abstract">We previously shown that in a Turkish population, the A/G polymorphism in exon 1 of the cytotoxic T cell lymphocyte-associated molecule-4 (CTLA-4) gene is associated with Graves&#8217; disease, and that the G allele may contribute to susceptibility for developing Graves&#8217; disease. This polymorphism was identified in 197 patients with Hashimoto thyroiditis (HT) (126 women, 71 men; aged, 42.92 +/- 13.4 years) and 98 healthy individuals (56 women, 21 men; aged, 42.27 +/- 13.43 years) in Turkish population. Polymorphisms were analysed using a polymerase chain reaction-restriction fragment length polymorphism method. Frequency of the A/G genotypes was not significantly different in patients with HT when compared with controls in both sexes (P &gt; 0.05). There was no statistical difference in age, sex, cigarette smoking, initial serum thyroid hormone levels, initial goiter size and thyroid autoantibodies among the patients with the three different genotypes (G/G, A/G and A/A). We concluded that A/G polymorphism of CTLA molecule is linked to occurrence of Graves&#8217; disease bu not to HT in the Turkish population.</p>
</dd>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/cancer-kanser/kategorisiz/cytotoxic-t-lymphocyte-associated-molecule-4-polymorphism-in-turkish-patients-with-hashimoto-thyroiditis-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Polymorphisms of cytochrome P450 1A1, glutathione S-transferases M1 and T1 in a Turkish population.</title>
		<link>http://polymorphisms.info/gene-polymorphisms/polymorphisms-of-cytochrome-p450-1a1-glutathione-s-transferases-m1-and-t1-in-a-turkish-population.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/polymorphisms-of-cytochrome-p450-1a1-glutathione-s-transferases-m1-and-t1-in-a-turkish-population.html#comments</comments>
		<pubDate>Thu, 14 Aug 2008 18:53:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[CYP1A1]]></category>
		<category><![CDATA[Cytochrome P450]]></category>
		<category><![CDATA[GSTM1]]></category>
		<category><![CDATA[GSTP1]]></category>
		<category><![CDATA[GSTT1]]></category>
		<category><![CDATA[Gene polymorphisms]]></category>
		<category><![CDATA[Ada AO]]></category>
		<category><![CDATA[Ankara]]></category>
		<category><![CDATA[CYP]]></category>
		<category><![CDATA[Glutathione]]></category>
		<category><![CDATA[GST]]></category>
		<category><![CDATA[Intra-ethnic]]></category>
		<category><![CDATA[iscan]]></category>
		<category><![CDATA[Pharmacy]]></category>
		<category><![CDATA[RFLP]]></category>
		<category><![CDATA[suzen]]></category>
		<category><![CDATA[Tandogan]]></category>
		<category><![CDATA[toxicol]]></category>
		<category><![CDATA[transferase]]></category>
		<category><![CDATA[Turkey]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=124</guid>
		<description><![CDATA[Toxicol Lett. 2004 Jun 15;151(1):311-5.

Ada AO, Süzen SH, Iscan M.
Department of Toxicology, Faculty of Pharmacy, Ankara University, 06100 Tandogan, Ankara, Turkey.
Intra-ethnic as well as inter-ethnic differences are known to exist in the frequencies of cytochrome P450 (CYP) 1A1, glutathione S-transferase (GST) M1, and GSTT1 gene polymorphisms with which associations have been shown for several cancers. [...]]]></description>
			<content:encoded><![CDATA[<p style="text-align: justify;"><span title="Toxicology letters."><a href="javascript:AL_get(this, 'jour', 'Toxicol Lett.');">Toxicol Lett.</a></span> 2004 Jun 15;151(1):311-5.</p>
<dd class="abstract" style="text-align: justify;">
<div class="authors"><!--AuthorList--><a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Ada%20AO%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Ada AO</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22S%C3%BCzen%20SH%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Süzen SH</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Iscan%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Iscan M</strong></a>.</div>
<p class="affiliation">Department of Toxicology, Faculty of Pharmacy, Ankara University, 06100 Tandogan, Ankara, Turkey.</p>
<p class="abstract" style="text-align: justify;">Intra-ethnic as well as inter-ethnic differences are known to exist in the frequencies of cytochrome P450 (CYP) 1A1, glutathione S-transferase (GST) M1, and GSTT1 gene polymorphisms with which associations have been shown for several cancers. In this study, CYP1A1 m2, GSTM1, and GSTT1 gene polymorphisms were determined among 133 healthy individuals of a Turkish population. On the basis of polymerase chain reaction/restriction fragment length polymorphism (PCR/RFLP) methodology, the frequency of CYP1A1 m2 mutation was determined. The multiplex PCR protocol was used to determine the frequency of the deleted genotypes of both GSTM1 and GSTT1 genes. The frequencies of Ile/Ile (wild type), Ile/Val (heterozygous variant), and Val/Val (homozygous variant) CYP1A1 m2 genotypes were 90.2%, 9.8%, and 0%, respectively. The frequencies of the deleted GSTM1 (null) and GSTT1 (null) genotypes were 51.9% and 17.3%, respectively. These results show that the frequencies of the CYP1A1 m2, GSTM1, and GSTT1 gene polymorphisms in a Turkish population are similar to Caucasian populations.</p>
</dd>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/polymorphisms-of-cytochrome-p450-1a1-glutathione-s-transferases-m1-and-t1-in-a-turkish-population.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

